0
Articles |

Chest X-ray Screening Improves Outcome in Lung Cancer : A Reappraisal of Randomized Trials on Lung Cancer Screening FREE TO VIEW

Gary M. Strauss; Ray E. Gleason; David J. Sugarbaker
Author and Funding Information

From the Division of Medical Oncology, Dana-Farber Cancer Institute, and the Division of Hematology-Oncology, Clinical Research Center, Endocrinology and Hypertension Unit, Department of Medicine, and Division of Thoracic Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston


1995 by the American College of Chest Physicians


Chest. 1995;107(6_Supplement):270S-279S. doi:10.1378/chest.107.6_Supplement.270S
Text Size: A A A
Published online

Abstract

It is believed that population-based screening for cancer should be advocated only when screening reduces disease-specific mortality. Four randomized controlled studies on lung cancer screening have been conducted in male cigarette smokers, and none has demonstrated reduced mortality. Accordingly, no organization that formulates screening policy advocates any specific early detection strategies for lung cancer. Yet, despite this public policy against screening, there is considerable evidence that chest x-ray screening is associated with earlier detection and improved survival. Two randomized trials, the Memorial Sloan-Kettering and Johns Hopkins Lung Projects, were specifically designed to evaluate the effectiveness of sputum cytologic study. Both evaluated the efficacy of the addition of sputum cytologic studies to annual chest radiographs, and both demonstrated that cytologic study did not favorably influence outcome. All individuals in experimental and control groups in both studies had annual chest radiographs. Because survival rates observed in both studies were about three times higher than predicted, based either on the National Cancer Institute's Surveillance Epidemiology and End Results database or based on the American Cancer Society's annual Cancer Statistics, raises the possibility that the periodic chest radiographs performed in all patients in both studies contributed to an improved outcome. In the Mayo Lung Project and in the Czechoslovak study on lung cancer screening, the experimental groups underwent a program of relatively intensive and regular rescreening with chest radiographs and sputum cytologic study, while the control groups underwent either less-frequent rescreening or no rescreening. In both studies, the screened groups achieved meaningful improvements in stage distribution, resectability, and survival. However, increases in cumulative incidence of lung cancer in the experimental group in both studies (which in the Mayo Lung Project reached statistical significance) prevented significant improvements in survival from translating into corresponding reductions in mortality. The possibility that screening may be associated with lung cancer "overdiagnosis" has been widely postulated to account for higher survival and incidence rates and equivalent mortality rates. However, analysis of autopsy information and of disease outcome in individuals with screen-detected early stage lung cancer who do not undergo surgical resection strongly supports the conclusion that screening does not lead to overdiagnosis of lung cancer. Similarly, lead-time and length bias do not adequately account for the differences in cumulative incidence observed in the Mayo and Czech studies. Because chest radiographs lead to meaningful improvements in stage distribution, resectability, and survival in lung cancer, and because neither overdiagnosis bias nor lead-time bias accounts for these improvements in outcome, a reconsideration of the role of chest radiographs in the early detection of lung cancer would be appropriate. A consensus conference would be a suitable forum to reexamine fully the existing data on lung cancer screening and to formulate specific guidelines for early detection strategies in individuals at high risk for lung cancer.


This article is only available in the PDF format. Download the PDF

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543